Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

89
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
89
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

100
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
100
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

120
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
120
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

102
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
102
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

100
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
100
Pedigree Analysis01:35

Pedigree Analysis

87.4K
Overview
87.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nailfold Videocapillaroscopy in Pediatric Rheumatology: Established Roles, Emerging Applications, and Future Perspectives.

Balkan medical journal·2026
Same author

Systemic JIA-Associated Lung Disease: A Multicenter Analysis of Clinical Features, Treatment Challenges, and Outcomes.

Pediatric pulmonology·2026
Same author

What is the treatment pattern of juvenile systemic sclerosis? Results from an international cohort.

Journal of scleroderma and related disorders·2026
Same author

Factors Determining the Use of Systemic Glucocorticoid Treatment and Cumulative Dose During the First Year After Diagnosis of Juvenile Idiopathic Arthritis.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2026
Same author

Predictors of severe coronary involvement in children with Kawasaki disease: a single-centre cohort study.

Cardiology in the young·2026
Same author

Idiopathic recurrent pericarditis in children: a tertiary care cohort highlighting the emergence and effectiveness of interleukin-1 blockade.

European journal of pediatrics·2026

Related Experiment Video

Updated: Nov 16, 2025

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.2K

Pediatric Behçet's Disease.

Mehmet Yildiz1, Fatih Haslak1, Amra Adrovic1

  • 1Department of Pediatric Rheumatology, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.

Frontiers in Medicine
|February 22, 2021
PubMed
Summary
This summary is machine-generated.

Behçet's Disease (BD) is a rare systemic vasculitis affecting young adults, with pediatric cases showing distinct clinical features and better outcomes. Diagnosis relies on clinical findings, as specific tests are lacking.

Keywords:
Behçet's diseasechildrenclassificationclinical featuresepidemiologyjuvenilepediatrictreatment

More Related Videos

High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia
05:32

High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia

Published on: January 19, 2022

4.7K
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.2K

Related Experiment Videos

Last Updated: Nov 16, 2025

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.2K
High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia
05:32

High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia

Published on: January 19, 2022

4.7K
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.2K

Area of Science:

  • Rheumatology
  • Immunology
  • Pediatrics

Background:

  • Behçet's Disease (BD) is a systemic vasculitis characterized by oral/genital ulcers and uveitis.
  • It exhibits a unique geographic distribution along the historical Silk Road.
  • Etiopathogenesis involves genetic susceptibility and environmental/infectious triggers, with many mechanisms still unidentified.

Purpose of the Study:

  • To review the definition, clinical findings, epidemiology, etiopathogenesis, and treatment of Behçet's Disease.
  • To highlight the differences between pediatric and adult Behçet's Disease.
  • To discuss diagnostic challenges and therapeutic approaches.

Main Methods:

  • Review article synthesizing current knowledge on Behçet's Disease.
  • Analysis of clinical manifestations, epidemiological data, and etiological factors.
  • Examination of diagnostic criteria and treatment strategies.

Main Results:

  • Pediatric BD (15-20% of cases) presents differently from adult BD, with more GI, neurological, and arthralgia involvement.
  • Children generally experience better outcomes with lower disease severity.
  • Diagnosis is clinical, complicated by the lack of specific tests and delayed presentation in pediatric cases.

Conclusions:

  • Behçet's Disease diagnosis and management require a multidisciplinary approach.
  • Pediatric BD has unique characteristics influencing its outcome and requiring tailored diagnostic and treatment strategies.
  • Further research is needed to fully elucidate the underlying mechanisms of BD.